课题基金 / 基金详情

Studies of Normal and Neoplastic Prostate

Studies of Normal and Neoplastic Prostate
正常和肿瘤性前列腺的研究
批准号:
6728175
负责人:
Khalil Ahmed
金额:
$22.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-12-01 至 2009-08-31

项目摘要

项目成果

Khalil Ahmed的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the years, we have focused on investigation of the fundamental functional biology of protein kinase CK2 with a specific view to its role in the pathobiology of prostate cancer. CK2 is a ubiquitous highly conserved multifunctional protein ser/thr kinase that has long been implicated in cell growth and proliferation. Its importance in cancer is emphasized by its deregulation in all the cancers that have been examined, including prostate cancer. Our paradigm-shifting discovery that CK2 can also suppress apoptosis suggests, for the first time, an important new link between CK2 and oncogenesis since deregulation of apoptosis (especially in prostate cancer) is a key feature of cancer phenotype. Our working hypothesis is that CK2 plays crucial roles in normal and abnormal prostatic growth control, and its deregulation is critically associated with oncogenesis through its impact on cell growth, apoptosis, and survival. Our long-term goals are to investigate the mechanisms involved in CK2 signaling in cell growth and suppression of apoptosis, and to exploit the key features of CK2 functional pathobiology in translational studies targeted to prostate cancer. To this end, we propose (a) to investigate the mechanisms involved in shuttling of CK2 to the nuclear matrix; (b) to examine the mechanisms by which CK2 suppresses apoptosis; (c), to exploit its downregulation as a potential therapeutic modality; and (d) to target its overexpression for generating a new transgenic mouse model of prostate cancer. In summary, our studies on CK2 functional biology with reference to prostate cancer biology represent an important and unique area of investigation. Also significant is the application of this knowledge to the development of a new transgenic mouse model and a new therapeutic modality for prostate cancer. The relevance of these studies is underscored by the fact that prostate cancer is a leading cause of cancer-related deaths in men in the U.S.A.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamics of protein kinase CK2 signaling in prostate cancer pathogenesis
  • 批准号:
    10553127
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Khalil Ahmed
  • 依托单位:
Dynamics of protein kinase CK2 signaling in prostate cancer pathogenesis
  • 批准号:
    10341109
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Khalil Ahmed
  • 依托单位:
Mechanisms of CK2-regulated prostate cancer survival and death
  • 批准号:
    9032603
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Khalil Ahmed
  • 依托单位:
Modulation of Apoptosis in Prostate Cancer
  • 批准号:
    8458485
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2012
  • 负责人:
    Khalil Ahmed
  • 依托单位:
国内基金
海外基金
环境抗雄激素干预AR/TGFB1I1致尿道下裂血管内皮细胞发育异常的机制及其“预警信号”在早期诊断中的价值
  • 批准号:
    82371605
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    蒋君涛
  • 依托单位: